These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23129486)

  • 1. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.
    Cetin H; Fülöp G; Zach H; Auff E; Zimprich F
    Wien Klin Wochenschr; 2012 Nov; 124(21-22):763-8. PubMed ID: 23129486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
    Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
    Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    Carey IM; Banchoff E; Nirmalananthan N; Harris T; DeWilde S; Chaudhry UAR; Cook DG
    PLoS One; 2021; 16(12):e0261983. PubMed ID: 34972157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
    Lai CH; Tseng HF
    Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China.
    Fang W; Li Y; Mo R; Wang J; Qiu L; Ou C; Lin Z; Huang Z; Feng H; He X; Wang W; Xu P; Wang L; Ran H; Liu W
    Neurol Sci; 2020 May; 41(5):1211-1223. PubMed ID: 31897952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of myasthenia gravis in the Catalan county of Osona.
    Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
    Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of myasthenia gravis among rural adult populations.
    Nemet AY; Kaiserman I; Mimouni M; Segal O; Vinker S
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):47-50. PubMed ID: 25415514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of myasthenia gravis in northwestern Sardinia.
    Aiello I; Pastorino M; Sotgiu S; Pirastru MI; Sau GF; Sanna G; Rosati G
    Neuroepidemiology; 1997; 16(4):199-206. PubMed ID: 9267837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
    Robertson NP; Deans J; Compston DA
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.
    Foldvari A; Kovacs N; Sipos V; Merth G; Vincze F; Szucs M; Sandor J
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):459-64. PubMed ID: 25990531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis: a study from India.
    Singhal BS; Bhatia NS; Umesh T; Menon S
    Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
    Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.